Company News: Page (1) of 1 - 10/19/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Phase III Efficacy and Safety Data for Oral Ozanimod in Relapsing Multiple Sclerosis to Be Presented at MSParis2017 7th Joint ECTRIMS ACTRIMS Meeting

(October 19, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved